TP53 and neoplasm: As a central player in the HR mechanism, RAD51 is overexpressed in tumor cells, because malignant cancer cells often bear p53 mutations in tandem with a low-level DNA damage sensitivity caused by chemo- and radiotherapy treatment [120,128,129,130,131].